In a striking departure from her once-fervent loyalty, former Congresswoman Marjorie Taylor Greene has launched a scathing critique of Donald Trump and his MAGA movement, accusing him of abandoning his base for wealthy donors and foreign interests, particularly Israel.
The CrossCurve decentralized finance protocol has suffered a $3 million exploit through a vulnerability in its cross-chain bridge, contributing to a devastating start to 2026 that has seen nearly $400 million stolen from the crypto sector.
Israel and Egypt have initiated a tightly controlled pilot reopening of the Rafah border crossing, a move tied to the broader U.S.-backed peace framework. The initial phase permits a small number of pre-vetted individuals to cross daily under heavy security coordination.
The vital Rafah border crossing between Gaza and Egypt has partially reopened for a trial period, allowing a restricted number of Palestinian civilians to cross. This move implements a key provision of the U.S.-mediated ceasefire, though severe limitations and high costs cast doubt on its immediate humanitarian impact.
The Rafah border crossing between Gaza and Egypt reopened for pedestrian traffic Monday, ending a near two-year shutdown. The vital gateway, crucial for aid and movement, resumes under a complex new security framework involving Israeli oversight and international monitors.
The death of Alicia Harnishfeger, discovered under a downtown bridge during a severe cold snap, has sparked conversations about systemic failures in addressing homelessness intertwined with mental health and substance abuse crises.
The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.
With shares languishing near $5.74, Bausch Health Companies (BHC) presents a stark valuation puzzle. While a standard DCF model suggests a staggering 91% undervaluation, the market's persistent sell-off reflects deep-seated concerns over the company's restructuring path and debt burden. We examine the numbers behind the divergence.
Greenlight Capital has spotlighted Core Natural Resources (CNR), the entity formed from the merger of Arch Resources and CONSOL Energy, as a key coal investment. The fund cites the company's valuation and combined asset base, even as the sector grapples with operational challenges. This endorsement brings renewed scrutiny to CNR's integration path and its strategy in a complex market.
A recent discounted cash flow analysis suggests D&O Green Technologies Berhad's stock may be significantly undervalued, trading around RM0.60 against a calculated fair value of RM0.89. The semiconductor-focused firm's current valuation presents a notable gap for investors to consider.
Facing a significant stock decline and a challenging Medicare Advantage outlook, UnitedHealth Group announces leadership changes and a 'Back to Basics' operational reset, aiming to stabilize its core business amid shifting market dynamics.
Construction giant Skanska has secured a landmark joint venture for a central Oslo redevelopment with Entra, alongside new major contracts in Norway and Finland, reinforcing its strategic pivot towards complex, sustainability-focused projects in the region.
A federal judge has removed the death penalty as an option for Luigi Mangione, accused of assassinating a top health insurance executive in New York. The ruling narrows the federal case while state murder charges proceed.
RBC Capital reaffirms its Outperform rating on UnitedHealth Group, citing management's commitment to long-term earnings targets, even as a lower-than-expected Medicare Advantage rate proposal triggers a sharp sell-off in the health insurer's shares.
Omega Healthcare Investors (OHI) maintains its quarterly dividend, offering a signal of stability to income-focused shareholders as the healthcare REIT navigates tenant health and leverage concerns in a challenging operating environment.
A week of significant stock swings saw Lockheed Martin and Texas Instruments surge on strong outlooks, while Humana plunged on regulatory headwinds. Here’s what drove the action and what analysts are saying.
While the healthcare sector has significantly outperformed the broader market, surging 17.4% in six months, not all companies are positioned to thrive. Intense competition and shifting market dynamics pose risks for some established players. We examine three stocks where investors may want to exercise caution.
The healthcare sector has surged 17.4% in six months, outpacing the S&P 500. While demographic trends fuel long-term growth, regulatory hurdles and valuation concerns demand selective investing. We analyze one company built for decades of returns and two where investors should tread carefully.
Israel announces a limited reopening of the Rafah border crossing between Gaza and Egypt this Sunday, permitting the movement of people under strict security protocols for the first time since its capture in May 2024.
A social media poll by billionaire Mark Cuban reveals a near-even split on which part of U.S. health insurance is more financially painful—premiums or deductibles. The results, and the outpouring of personal stories in the replies, underscore a system many describe as forcing impossible choices amid relentlessly rising costs.
